Explore key questions on contamination control strategies to support regulatory compliance and risk management in ...

Pharmaceutical Research and Manufacturers of America President and CEO Steve Ubl plans to step down at the end of 2026. Steve Ubl has led PhRMA, the largest pharmaceutical lobbying group in the ...

MARSEILLE, France--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company"), announced today that Yannis Morel, Chief Operating Officer, will ...

After a wave of high-profile pledges to bring pharmaceutical manufacturing back to the United States, a clearer picture of what reshoring actually looks like is starting to emerge. Tens of billions of ...

The Trump administration imposed new tariffs on branded drugs from pharmaceutical companies that have not struck landmark deals with the president to lower their U.S. drug prices. Patented medications ...

1. The Secretary of Commerce (Secretary) recently transmitted to me a report on his investigation into the effects of imports of pharmaceuticals and pharmaceutical ingredients on the national security ...

President Donald Trump on Thursday ordered a new 100 percent tariff on imported drugs made by companies that have not agreed to lower their retail prices, the latest move in his evolving campaign to ...

Iran’s foreign minister, Abbas Araghchi, said on Tuesday that Israel was “openly and unashamedly bombing pharmaceutical companies.” By Parin Behrooz and Ephrat Livni Israeli missiles struck a major ...

Ireland manufactures some of the world's most in demand medicines — from Viagra and Botox to the blockbuster weight loss drug Mounjaro. In just 50 years, it has become the world's third largest ...

Stakeholders are being encouraged to weigh in on the European Chemicals Agency (ECHA) 60-day public consultation period related to a planned ban on per-and-polyfluoroalkyl (PFAS) substances, also ...

As President Trump’s war in Iran rages on, it’s posing a growing threat to the pharmaceutical supply chain and risks spiking the prices of many drugs, particularly those that depend on petrochemicals.